Mexico Creates Fast-Track Approval for Drugs Cleared by Brazil's Anvisa

Mexico will expedite approval of certain drugs already authorized by Brazil's Anvisa, a move announced during a Mexican delegation's visit to Brazil to discuss a SUS-inspired universal health system. The measure, effective October, is expected to boost Brazilian pharmaceutical exports, which currently face a trade deficit. The scope of drugs covered and the regulatory details remain unspecified.